Instruction for use: Mebicar tablets

Dosage form: tablets

Active substance: Tetramethyltetraazabicyclooctandione

ATX

N05BX Others Anxiolytics

Pharmacological group:

Anxiolytic agent (tranquilizer) [Anxiolytics]

The nosological classification (ICD-10)

F10.2 Syndrome of alcohol dependence: Alcoholism; Alcohol addiction; posiomania; Dependence on alcohol; dipsomania; drunken state; alcohol abuse; Ideatornoy violations in alcoholism; Quarterly booze; Obsessive craving for alcohol; Neurotic symptoms of alcoholism; Craving for alcohol; Psychoorganic syndrome in chronic alcoholism; Reduced craving for alcohol; chronic alcoholism

F17.2 Nicotine addiction: Craving for smoking; Attraction to smoking tobacco; Tobacco dependence; Abstinence syndrome with smoking cessation; Abuse of nicotine

F28 Other Inorganic Psychotic Disorders: Affective psychoses; Involutional psychosis; Psychoinstrumental; Psycho senile; Senile psychosis; An old-time involutionary psychosis; Static psychosis

F48.0 Neurasthenia: Asthenic form of neurasthenia; Asthenoneurotic disorder; Astheno-neurotic state; Flu of young workaholics; Influenza yuppie; Neurasthenic disorders; Neurasthenic conditions; Neurasthenic syndrome

R07.2 Pain in the heart: neuroses of the heart; Myocardial ischemic pain; Pain syndrome in myocardial infarction; cardialgia; cardioneurosis; Cardiac syndrome; Pain in cardiac patients; Cardialgia on background dyshormonal myocardial dystrophy; Functional cardialgia; Psevdostenokardiya; pericardial pain

R45.4 Irritability and anger: Neurosis with increased irritability; Outbursts of anger; Anger; Resentment; Increased irritability; Increased irritability of the nervous system; Irritability; Irritability in neuroses; Irritability in psychopathic disorders; Symptoms of irritability; Dysphoria

T65.2 Toxic effect of tobacco and nicotine

Composition and release form

1 tablet contains mebicara 0.3 g; in a contour blister box 10 pcs., in a cardboard bundle 2 packs.

Pharmachologic effect

Mode of action - tranquilizing.

Pharmacodynamics

Potentsiruet effect of hypnotics and other deprimiruyuschih funds, regulates disturbed sleep at night, without giving a direct hypnotic effect. Has no cholinolytic and muscle relaxant effect, does not violate the coordination of movements. Relieves or removes nicotine withdrawal.

Pharmacokinetics

It is excreted completely in the urine within 24 hours.

Indications Mebicar tablets

Neuroses and neurosis-like conditions, cardialgia (not associated with ischemic heart disease); a decrease in craving for tobacco smoking, neurosis-like conditions in patients with alcoholism during remission (asthenia, irritability, mood deterioration, obsessive attraction to alcohol). To improve the tolerability of neuroleptics and tranquilizers.

Contraindications

Hypersensitivity.

Side effects

Rarely - dyspeptic phenomena, allergic reactions.

Interaction

You can combine with neuroleptics, hypnotics, antidepressants and psychostimulants.

Dosing and Administration

Inside, regardless of food intake - 0.3-0.6 g 3 times a day for the treatment of tobacco - 0.6-0.9 g 3 times a day, to improve the tolerability of neuroleptics and tranquilizers - 0.9- 3.6 g / day, patients with alcoholism - 1.5-2.1 g / day. The maximum single dose - 3 grams, daily - 10 g. Duration of treatment from several days to 2-3 months, with light situational disorders, a single reception is sufficient for healthy people.

Storage conditions of the drug Mebicar tablets

In the dark place.

Keep out of the reach of children.

Shelf life of the drug Mebicar tablets

4 years.

Do not use after the expiry date printed on the package.